3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Hemorrhage
1
Interventions
Cyclophosphamide
57
fludarabine phosphate
48
Tacrolimus
39
Peripheral Blood Stem Cell Transplantation
37
Busulfan
36
Mycophenolic Acid
34
Whole-Body Irradiation
31
Antilymphocyte Serum
28
Methotrexate
26
Cyclosporine
25
fludarabine
23
Melphalan
18
Filgrastim
15
Radiotherapy
14
thymoglobulin
12
ruxolitinib
12
Methylprednisolone
12
Cord Blood Stem Cell Transplantation
12
Stem Cell Transplantation
11
Sirolimus
11
Psychiatric Rehabilitation
9
Flow Cytometry
9
Etoposide
9
Specimen Handling
7
Granulocyte Colony-Stimulating Factor
7
merphos
6
Therapeutics
6
Decitabine
6
Cyclosporins
6
Azacitidine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Primary Myelofibrosis
×
N(4)-oleylcytosine arabinoside
×
Clear all
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled